Child Neurology Society (CNS): Annual Meeting
Conference Coverage
In childhood sickle cell disease stroke prevention is key
“Children with sickle cell disease have 100 times the risk of stroke as other children without sickle cell disease.”
Conference Coverage
Psychiatric comorbidities in the pediatric neurology clinic
Neurologists are in a unique position to help recognize and treat psychological comorbidities in their patients.
Conference Coverage
Diazepam nasal spray effective in Lennox-Gastaut syndrome
A post hoc analysis shows that the drug works about as well in Lennox-Gastaut syndrome as in patients with pediatric encephalopathies.
Conference Coverage
In epilepsy, heart issues linked to longer disease duration
Researchers hope to tease out mechanism of cardiovascular risk to improve monitoring and prevention.
Conference Coverage
NICU signs hint at cerebral palsy risk
“Infants who are at higher risk for developing cerebral palsy had more respiratory instability early on in life.”
Conference Coverage
Cerebral palsy: Video clues suggest dystonia
Key movements could both aid diagnosis dystonia in patients with cerebral palsy and hint at differences in brain injury.
Conference Coverage
Pandemic survey: Forty-six percent of pediatric headache patients got worse
But some fared better when they were stuck at home instead of at school.
Conference Coverage
Pandemic data challenges infection link to Guillain-Barré syndrome
Pediatric infectious cases plummeted during the early months of COVID-19, but AIDP had a gentler dip.
Conference Coverage
Epidiolex plus THC lowers seizures in pediatric epilepsy
But neurologists caution colleagues to be careful with the intoxicating cannabis component.
Conference Coverage
Case reports underscore risk of cerebral edema, AFCE in children with COVID-19
Neurologists urge colleagues to watch for similar cases in children.
Conference Coverage
Maternal SSRI use linked to more encephalopathy in newborns, risk still small
Overall risk remains extremely small, large retrospective study finds.
Conference Coverage
Gene-replacement therapy shows promise in X-linked myotubular myopathy
An investigational gene therapy decreases ventilator dependence and may improve motor development in children with a rare, life-threatening...
Conference Coverage
ODC1 gene linked to newly described neurodevelopmental disorder
A previously undescribed neurometabolic disease has been linked to a gain-of-function mutation of the ODC1 gene.
Conference Coverage
Ataluren delays disease milestones in patients with nonsense mutation DMD
Patients who received ataluren in addition to standard of care were 2.2 years older when they lost ambulation, compared with patients receiving...
Conference Coverage
Newer DMTs are more effective than injectable DMTs in pediatric MS
A retrospective study suggests that the safety and tolerability of newer disease-modifying therapies are the same in children as in adults.